GENENTA SCIENCE(SP.ADR)/1 (K5F) — Net Asset Quality Index
GENENTA SCIENCE(SP.ADR)/1 (K5F) has a Net Asset Quality Index of 68.5% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €31.89 Million minus total liabilities of €10.05 Million yields net assets of €21.84 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read total liabilities of GENENTA SCIENCE(SP.ADR)/1 for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
GENENTA SCIENCE(SP.ADR)/1 Net Asset Quality Index Over Time (2021–2025)
This chart shows how GENENTA SCIENCE(SP.ADR)/1's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the index stands at 68.5%, representing net assets of €21.84 Million against total assets of €31.89 Million EUR. For live market cap and overall valuation, see K5F market cap.
Annual Net Asset Quality Index for GENENTA SCIENCE(SP.ADR)/1 (2021–2025)
The table below presents the year-by-year Net Asset Quality Index for GENENTA SCIENCE(SP.ADR)/1 from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See GENENTA SCIENCE(SP.ADR)/1 shareholders equity for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 68.5% | €21.84 Million | €31.89 Million | €10.05 Million | ▼ -15.8 pp |
| 2024 | 84.3% | €12.50 Million | €14.82 Million | €2.33 Million | ▼ -7.1 pp |
| 2023 | 91.4% | €20.43 Million | €22.35 Million | €1.91 Million | ▼ -1.7 pp |
| 2022 | 93.1% | €31.14 Million | €33.44 Million | €2.30 Million | ▼ -4.0 pp |
| 2021 | 97.1% | €38.86 Million | €40.03 Million | €1.17 Million | — |